Corient Private Wealth
GSK icon

Corient Private Wealth’s GSK GSK Stock Holding History

Corient Private Wealth’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.52M Buy
105,377
+864
+0.8% +$45.7K 0.01% 862
2026
Q1 		$5.71M Sell
104,513
-3,491
-3% -$189K 0.01% 806
2025
Q4 		$5.3M Sell
108,004
-15,255
-12% -$711K 0.01% 750
2025
Q3 		$5.32M Buy
123,259
+31,273
+34% +$1.22M 0.01% 691
2025
Q2 		$3.53M Sell
91,986
-4,025
-4% -$154K ﹤0.01% 813
2025
Q1 		$3.72M Sell
96,011
-333
-0.3% -$12.2K 0.01% 767
2024
Q4 		$3.26M Buy
96,344
+10,895
+13% +$392K 0.01% 828
2024
Q3 		$3.49M Buy
85,449
+6,395
+8% +$262K 0.01% 866
2024
Q2 		$3.04M Buy
79,054
+4,926
+7% +$207K 0.01% 864
2024
Q1 		$3.18M Buy
74,128
+6,564
+10% +$271K 0.01% 835
2023
Q4 		$2.5M Sell
67,564
-1,014
-1% -$36.4K ﹤0.01% 905
2023
Q3 		$2.49M Sell
68,578
-129
-0.2% -$4.58K 0.01% 838
2023
Q2 		$2.45M Buy
68,707
+6,922
+11% +$248K 0.01% 836
2023
Q1 		$2.2M Buy
61,785
+29,016
+89% +$1.02M 0.01% 813
2022
Q4 		$1.16M Buy
+32,769
New +$1.09M ﹤0.01% 867

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Corient Private Wealth's GSK Position: Q2 2026 in Review

Corient Private Wealth increased its GSK (GSK) stake by 0.83% in Q2 2026, buying an estimated $45.7K and bringing the position to 105,377 shares worth $5.52M. The position accounts for 0.01% of the portfolio, ranked #862.

Corient Private Wealth first reported a position in GSK in Q4 2022 and has held it in 15 quarters since. The position peaked at $5.71M in Q1 2026. 1,042 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Corient Private Wealth held 105,377 shares of GSK worth $5.52M as of Q2 2026.
  • Corient Private Wealth bought 864 GSK shares in Q2 2026, an estimated $45.7K.
  • GSK made up 0.01% of Corient Private Wealth's portfolio in Q2 2026, its #862 holding.
  • Corient Private Wealth first reported a position in GSK in Q4 2022 and has held it in 15 quarters since.
  • Corient Private Wealth's GSK position peaked at $5.71M in Q1 2026.
  • 1,042 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.